📢 #Gate Square Writing Contest Phase 3# is officially kicks off!
🎮 This round focuses on: Yooldo Games (ESPORTS)
✍️ Share your unique insights and join promotional interactions. To be eligible for any reward, you must also participate in Gate’s Phase 286 Launchpool, CandyDrop, or Alpha activities!
💡 Content creation + airdrop participation = double points. You could be the grand prize winner!
💰Total prize pool: 4,464 $ESPORTS
🏆 First Prize (1 winner): 964 tokens
🥈 Second Prize (5 winners): 400 tokens each
🥉 Third Prize (10 winners): 150 tokens each
🚀 How to participate:
1️⃣ Publish an
CoinVoice has learned that, according to strategic transformation information led by Titan Partners Group and the encryption investment company GSR, the American pharmaceutical company MEI Pharma (NASDAQ: MEIP) is advancing its establishment of a dedicated Litecoin treasury strategy. Currently, over 100 million dollars in funding commitments have been made for this project.
It is worth mentioning that Litecoin founder Charlie Lee has agreed to join the board of MEI Pharma.
In addition, the Litecoin Foundation has also invested in MEI Pharma, as the company's treasury strategy aligns closely with the core mission of the Litecoin Foundation to promote global adoption of Litecoin.